As of late, it has definitely been a great time to be an investor in BioTelemetry, Inc. (BEAT Quick QuoteBEAT - Free Report) . The stock has moved higher by 8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider BEAT’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as BEAT has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks’ Best Private Investment Ideas                                                                                                                 

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.    

                                                                                                                                                                            Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>